Anavex Life Sciences Corp (AVXL)

[tootalljones]

It is not that management is at fault, it is just that the drug candidate is no good. It is simply not powerful enough. What is confusing is that the company has hired quite a few individuals the past couple years, sensing, I suppose that the product would at least get it approved in RETT. Now that hope has been dashed and the company is left with a lot of former government workers. This whole strategy has failed. They rolled the dice and now are taking a shot at skitzo, all other avenues have been failures.

Because IF the company has money in the bank, they should simply have already bought another drug candidate or two in a completely unrelated field. Get away from the neurology field because 9 out of 10 times, the products will fail.
But herr Dioktor M will not do that. That would be too humbling, and really jolt the share price.
But IF he announced they are completely changing the direction of the company, and have over 100 million plus in the bank, and are terminating all these new hires, I think the market would like that. This would take a man with guts and vision. But of course, you would need to have the entirely new drug candidate or candidates already in your stable. This obviously will not be done.
So the company is gonna just ride the bankroll out. This is how failed companies go.